A Case series on Utilization of N-Acetylcysteine for Acute Kidney Injury in patients with Diabetes Mellitus
Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Neyattinkara, Kerala-695131, India.
Research Article
World Journal of Biology Pharmacy and Health Sciences, 2023, 14(03), 036–041.
Article DOI: 10.30574/wjbphs.2023.14.3.0226
Publication history:
Received on 15 April 2023; revised on 04 June 2023; accepted on 07 June 2023
Abstract:
N-Acetylcysteine is commonly used for paracetamol overdose. It has also been used for acute kidney injury and slowing the progression of CKD. Here we portray three cases that use N-Acetylcysteine in IV and Oral forms for treatment of the Acute kidney injury in patients with Type 2 Diabetes Mellitus. The case series focuses on the need for guidelines to be implemented for the use of IV N-Acetylcysteine in these patients.
Keywords:
N-Acetylcysteine; Acute kidney injury; Type 2 Diabetes Mellitus
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0